drugset / Trial / NCT03384823
A Study of EDP-938 in Healthy Subjects
Phase 1
Completed
90 enrolled
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This randomized, double-blind, placebo-controlled study will assess the safety, tolerability, and pharmacokinetics of single and multiple orally administered doses of EDP-938 in healthy adult subjects
Timeline
- Start
- 2017-12-07
- Primary completion
- 2018-07-03
- Completion
- 2018-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | zelicapavir | Small molecule | — | Oral |